Laparotomy Clinical Trial
Official title:
Enhanced Recovery After Surgery: A Randomized Control Trial of Perioperative Management of Gynecologic Patients
Verified date | July 2017 |
Source | Case Comprehensive Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a single-blinded randomized control trial comparing the current perioperative care of the investigators gynecologic oncology patients with a standardized perioperative "enhanced recovery" pathway. Adult patients undergoing laparotomy by one of the gynecologic oncology surgeons will be eligible to participate. The primary outcome will be length of hospitalization including any days of readmission in the 30 days post-operatively. Secondary outcomes will include 30-day readmission rate, complications, quality of recovery, and pain control.
Status | Completed |
Enrollment | 40 |
Est. completion date | July 3, 2017 |
Est. primary completion date | July 3, 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patients who are to undergo laparotomy Exclusion Criteria: - Inability to provide informed consent - Inability to comprehend written or spoken English - Immobility as defined by inability to ambulate unassisted - Patient currently residing in a skilled nursing facility - ASA physical status 4 or 5 - Planned greater than one night admission to the ICU - Pregnancy |
Country | Name | City | State |
---|---|---|---|
United States | Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center | Cleveland | Ohio |
Lead Sponsor | Collaborator |
---|---|
Case Comprehensive Cancer Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Length of hospitalization | Hospital days in first 30 days post-operatively (Length of stay of primary hospitalization plus any days of readmission) | 30 days post-operatively | |
Secondary | Readmission rate | 30 days post-operatively | ||
Secondary | Complications | as assessed by the incidence of a composite of major complications and a second composite of minor complications. Major complications: Deep surgical site infection, Organ/space infection, Sepsis, Bowel perforation, obstruction and/or anastomotic leak, Bleeding, Internal or external fistula formation, Pulmonary emboli (PE), Pulmonary edema with congestive heart failure, Acute heart failure, Myocardial infarction, Ventricular arrhythmias, Renal failure, Respiratory failure (including aspiration), Pneumonia Minor complications: Superficial incisional surgical site infection, Postoperative fever, Unplanned ICU admission, Non-ventricular arrhythmias, Paralytic Ileus, DVT, Cystitis or urinary tract infection, Urinary retention, Hemodynamic disturbances, Renal insufficiency, Transient neurological complication |
30 days post-operatively | |
Secondary | Quality of life/recovery | Patient reported quality of recovery and quality of life as determined by QoR-40 score and RAND-36 score | 30 days post-operatively | |
Secondary | Pain control | Pain control at assessed by daily mean pain scores (scale 0-10) as elicited and recorded by nursing. | 30 days post-operatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT03234543 -
Remote Ischemic Conditioning in Abdominal Surgery
|
N/A | |
Completed |
NCT03827291 -
QL Block With Exparel in Colectomy
|
Phase 4 | |
Recruiting |
NCT01719796 -
Effect of TAP Block on Ventilatory Function Following Abdominal Surgery
|
Phase 2 | |
Completed |
NCT02596269 -
Nefopam/Fentanyl Postoperative Intravenous Patient-Controlled-Analgesia
|
Phase 2/Phase 3 | |
Completed |
NCT00364741 -
Supplemental Oxygen and Complications After Abdominal Surgery (The PROXI-trial)
|
Phase 4 | |
Completed |
NCT01723280 -
Supplemental Oxygen - Effect on Occurrence of Subsequent Cancer After Abdominal Surgery (Follow-up of the PROXI Trial)
|
N/A | |
Terminated |
NCT00514566 -
PDS vs Polyamide for Midline Abdominal Closure
|
N/A | |
Recruiting |
NCT06089551 -
Early vs Postponed Parenteral Nutrition After Emergency Abdominal Surgery
|
Phase 4 | |
Withdrawn |
NCT03966768 -
DuraMesh Laparotomy Study
|
N/A | |
Recruiting |
NCT04985695 -
Influence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy
|
N/A | |
Recruiting |
NCT03739944 -
Different Surgical Approaches in Patients of Early-stage Cervical Cancer
|
Phase 3 | |
Terminated |
NCT01890408 -
Continuous Preperitoneal Infusion of Ropivacaine After Open Liver Resection: Effect on Post-operative Recovery and Morbidity.
|
Phase 2 | |
Recruiting |
NCT00544583 -
Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy
|
Phase 2/Phase 3 | |
Recruiting |
NCT04256798 -
Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
|
Phase 3 | |
Recruiting |
NCT03738969 -
Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer
|
||
Completed |
NCT03989570 -
Transversus Abdominis Plane Block Versus Erector Spinae Plane Block
|
N/A | |
Not yet recruiting |
NCT04266535 -
TCI vs Manually Controlled Infusion of Propofol
|
||
Completed |
NCT04065607 -
Indications and Outcome of Laparostomy
|
||
Completed |
NCT01040013 -
Gut Oxygenation and Laparoscopy
|
Phase 2 | |
Completed |
NCT00637936 -
Respiratory Effects of Perioperative Oxygen During General Anaesthesia
|
Phase 4 |